These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21426030)

  • 41. Horizontal gene transfer in eukaryotic parasites: a case study of Entamoeba histolytica and Trichomonas vaginalis.
    Alsmark UC; Sicheritz-Ponten T; Foster PG; Hirt RP; Embley TM
    Methods Mol Biol; 2009; 532():489-500. PubMed ID: 19271203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Intestinal and extraintestinal amebiasis: clinical notes].
    Tokmalaev AK; Astaf'eva NV; Bykova RN; Korovushkin VG; Kuznetsov EF; Mikhalevskaia LA; Tonkoglaz VN
    Med Parazitol (Mosk); 2005; (2):18-21. PubMed ID: 15984611
    [No Abstract]   [Full Text] [Related]  

  • 43. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.
    Ramírez-Ledesma MG; Rodríguez MC; Alva-Murillo N; Avila EE
    Parasitol Res; 2022 Dec; 121(12):3503-3512. PubMed ID: 36171407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Imidazoles in the treatment of infections due to parasitic protozoa "lumenals". (T. vaginalis, Giardia intestinalis, E. histolytica--general principles)].
    Grassi GG
    G Ital Chemioter; 1976; 23(1):41-6. PubMed ID: 196967
    [No Abstract]   [Full Text] [Related]  

  • 46. Poached egg appearance in intestinal amebiasis.
    Upadhyay R; Gupta N; Gogia P; Chandra S
    Gastrointest Endosc; 2012 Jul; 76(1):189-90. PubMed ID: 22726481
    [No Abstract]   [Full Text] [Related]  

  • 47. Synthesis of some 4-oxo-delta 2-thiazolin-2-ylhydrazones as potential antiprotozoal agents.
    Alves AJ; Leite AC; De Santana DP; Beltrao TM; Coelho MR; Gayral P
    Farmaco; 1993 Aug; 48(8):1167-71. PubMed ID: 8216678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metronidazole and Secnidazole Carbamates: Synthesis, Antiprotozoal Activity, and Molecular Dynamics Studies.
    Rocha-Garduño G; Hernández-Martínez NA; Colín-Lozano B; Estrada-Soto S; Hernández-Núñez E; Prieto-Martínez FD; Medina-Franco JL; Chale-Dzul JB; Moo-Puc R; Navarrete-Vázquez G
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32059495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of SQ109 on Trichomonas vaginalis.
    de Souza TG; Granado R; Benaim G; de Souza W; Benchimol M
    Exp Parasitol; 2023 Jul; 250():108549. PubMed ID: 37196704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron-saturated lactoferrin and pathogenic protozoa: could this protein be an iron source for their parasitic style of life?
    Ortíz-Estrada G; Luna-Castro S; Piña-Vázquez C; Samaniego-Barrón L; León-Sicairos N; Serrano-Luna J; de la Garza M
    Future Microbiol; 2012 Jan; 7(1):149-64. PubMed ID: 22191452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and antiprotozoal activity of nitazoxanide-N-methylbenzimidazole hybrids.
    Soria-Arteche O; Hernández-Campos A; Yépez-Mulia L; Trejo-Soto PJ; Hernández-Luis F; Gres-Molina J; Maldonado LA; Castillo R
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6838-41. PubMed ID: 24183540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trichomoniasis: challenges to appropriate management.
    Wendel KA; Workowski KA
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S123-9. PubMed ID: 17342665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Keto-acid oxidoreductases in the anaerobic protozoa.
    Upcroft JA; Upcroft P
    J Eukaryot Microbiol; 1999; 46(4):447-9. PubMed ID: 10461388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dealing with trichomoniasis.
    Young F
    J Fam Health Care; 2006; 16(5):153-5. PubMed ID: 17139977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trichomoniasis--an important cofactor of human immunodeficiency virus infection.
    Serwin AB; Koper M
    Przegl Epidemiol; 2013; 67(1):47-50, 131-4. PubMed ID: 23745375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.
    Bouchemal K; Bories C; Loiseau PM
    Clin Microbiol Rev; 2017 Jul; 30(3):811-825. PubMed ID: 28539504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
    Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
    Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity.
    Muzny CA; Van Gerwen OT; Kissinger P
    Curr Opin Infect Dis; 2020 Feb; 33(1):73-77. PubMed ID: 31789671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaerobic energy metabolism in human microaerophile parasites.
    Carvalho-de-Araújo AD; Carvalho-Kelly LF; Meyer-Fernandes JR
    Exp Parasitol; 2023 Apr; 247():108492. PubMed ID: 36841468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.